CIK 0001855485 · <br>Emerging growth company
Calidi Biotherapeutics, Inc.
Sign in to watch- Tickers
- CLDI CLDWW
- Exchange
- NYSE, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 862967193
- Phone
- 858-794-9600
- Business address
- 4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Calidi Biotherapeutics, Inc., First Light Acquisition Group, Inc.
Securities
- CLDI Calidi Biotherapeutics, Inc. Common Stock NYSE
- CLDWW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-09 | Stewart Alan R. Director | Grant or award · Non-Qualified Stock Options (right to buy) | +137,078 | 137,078 | ||
| 2025-07-09 | Schoeneck James A Director | Grant or award · Non-Qualified Stock Options (right to buy) | +164,493 | 164,493 | ||
| 2025-07-09 | Peoples George Director | Grant or award · Non-Qualified Stock Options (right to buy) | +137,078 | 137,078 | ||
| 2025-07-09 | Leftwich Scott Director | Grant or award · Non-Qualified Stock Options (right to buy) | +137,078 | 137,078 | ||
| 2025-04-22 | Poma Eric E Chief Executive Officer | Grant or award · Stock Option (right to buy) | +726,412 | 726,412 | ||
| 2024-12-31 | Stewart Alan R. Director | Grant or award | +12,771 | 28,976 | ||
| 2024-12-31 | Leftwich Scott Director | Grant or award | +11,684 | 67,774 | ||
| 2024-12-17 | Camaisa Allan CEO and Chairman of the Board | Sale | −10,000 | $1.62 | $16K | 66,712 |
| 2024-09-26 | Camaisa Allan CEO and Chairman of the Board | Grant or award | +70,155 | $1.15 | $81K | 76,712 |
| 2024-09-20 | Stewart Alan R. Director | Grant or award · Non-Qualified Stock Options (right to buy) | +20,217 | 20,217 | ||
| 2024-09-20 | Schoeneck James A Director | Grant or award · Non-Qualified Stock Options (right to buy) | +20,217 | 20,217 | ||
| 2024-09-20 | Peoples George Director | Grant or award · Non-Qualified Stock Options (right to buy) | +20,217 | 20,217 | ||
| 2024-09-20 | Leftwich Scott Director | Grant or award · Non-Qualified Stock Options (right to buy) | +20,217 | 20,217 | ||
| 2024-07-01 | Peoples George Director | Grant or award · Non-Qualified Stock Options (right to buy) | +30,904 | 30,904 | ||
| 2024-06-28 | Leftwich Scott Director | Grant or award | +67,187 | 560,873 | ||
| 2024-06-28 | Schoeneck James A Director | Grant or award | +79,687 | 1,071,781 | ||
| 2024-06-28 | Stewart Alan R. Director | Grant or award | +73,437 | 154,087 | ||
| 2024-06-17 | Minev Boris Radoslavov Interim Chief Medical Officer | Grant or award · Stock Options (right to buy) | +31,360 | 31,360 | ||
| 2024-06-17 | Jackson Andrew C. Chief Financial Officer | Grant or award · Stock Options (right to buy) | +300,000 | 300,000 | ||
| 2024-06-17 | Campbell Wendy Pizarro Chief Admin. and Legal Officer | Grant or award · Stock Options (right to buy) | +40,000 | 40,000 |
Page 2 of 4 · 78 trades